Inovio Pharmaceuticals, Inc. announced today that its SynConA DNA vaccine containing multiple malaria antigens delivered via its CELLECTRAA electroporation device demonstrated strong and durable antibody and T-cell immune responses in small animals and non-human primates.
http://www.drugs.com/news/inovio-pharmaceuticals-malaria-dna-vaccine-demonstrates-robust-immune-responses-animal-models-46756.html?
http://www.drugs.com/news/inovio-pharmaceuticals-malaria-dna-vaccine-demonstrates-robust-immune-responses-animal-models-46756.html?
No comments:
Post a Comment